Medline's IPO was the largest we've seen in over four years, says Jim Cramer

IPO Details - Medline had the largest IPO in over four years, offering $626 billion [1] - The IPO was unexpected, as Medline is not a widely recognized name [1] Business Model & Strategy - Medline's revenue is evenly split between its own brand medical surgical products and supply chain solutions [2] - Earnings are primarily derived from product sales [2] - The supply chain business provides insights into hospital needs and facilitates product distribution [2] - Medline aims to be the "Costco of healthcare" [3] - It employs a membership model through its supply chain business to offer healthcare providers the best prices [3] - Medline brand products are positioned similarly to Costco's Kirkland signature brand [3] Revenue Growth - Medline experienced solid revenue growth in recent years: 83% in 2023, 98% in 2024, and 103% through the first 9 months of 2025 [4] - Revenue growth appears to be accelerating [4]